You are here

TerrAscend Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
TER
CSE Index: 
Currency: 

TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator, with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. Additionally, TerrAscend will soon be the first and only cannabis company with sales in the US, Canada, and Europe as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario. TerrAscend operates a number of synergistic businesses, including Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; and Solace RX Inc., a proposed Drug Preparation Premises focused on the development of novel formulations and delivery forms.

You are here

TerrAscend Corp. (TER)

SEDAR Information

Company Info

Address
P.O. Box 43125
Mississauga, ON L5B 4A7
Canada
Phone
1-855-83772 - 95
Ext
105
Email
info@terrascend.com
Website
https://www.terrascend.com/
Listing date
Wednesday, May 3, 2017
Transfer Agent
TSX Trust Company
Investor Relations
Ari Unterman
Email
aunterman@TerrAscend.com
Auditor
MNP LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
52,982,656
Reserved for Issuance: 
39,420,605
Total equity shares, as if converted: 
133,594,755

Bulletins

02/05/2017

2017-0502 - New Listing - TerrAscend Corp. (TER)

May 2, 2017

The common shares of TerrAscend Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com

TerrAscend is a vertically integrated company that is focused on the production, sale and distribution of cannabis and its derivatives for the medical market. TerrAscend’s wholly-owned subsidiary, Solace Health Inc., is in the final stage of its application for licencing under the Access to Cannabis for Medical Purposes Regulations.

________________________

Advertisement

Publicité

Latest CSE News

Upcoming Events

09_21_RAISE_on_the_WEST_COAST_Conference_Website

RAISE on the WEST COAST Conference

Saturday, September 21, 2019 -
8:00am to 5:30pm
09-22_Extraordinary_Future_2019_Website

Extraordinary Future 2019

Sunday, September 22, 2019 (All day) to Monday, September 23, 2019 (All day)